OBERWEIS ASSET MANAGEMENT INC/ - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
OBERWEIS ASSET MANAGEMENT INC/ ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,929,100
-69.2%
50,500
-69.2%
0.20%
-78.9%
Q1 2023$6,264,688
-23.2%
164,040
+14.4%
0.97%
-43.9%
Q4 2022$8,158,891
+77.1%
143,390
+23.0%
1.73%
+60.9%
Q3 2022$4,608,000
+1.6%
116,540
+13.1%
1.08%
-6.0%
Q2 2022$4,534,000
+5.8%
103,050
-4.1%
1.15%
+33.7%
Q1 2022$4,285,000
+0.9%
107,450
+1.7%
0.86%
+10.7%
Q4 2021$4,248,000
+49.2%
105,650
+51.0%
0.78%
+31.4%
Q3 2021$2,847,000
-9.4%
69,980
+1.1%
0.59%
-14.2%
Q2 2021$3,142,000
+9.4%
69,200
+0.4%
0.69%
+17.2%
Q1 2021$2,872,00068,9000.59%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Third Security, LLC 7,048,282$126,799,00027.23%
First Light Asset Management, LLC 1,630,591$29,334,0005.01%
SNYDER CAPITAL MANAGEMENT L P 3,393,057$61,041,0003.48%
Bellevue Group AG 7,663,956$137,874,0002.67%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 307,633$5,531,0002.52%
Lombard Odier Asset Management (Switzerland) SA 900,000$16,191,0002.17%
Elk Creek Partners, LLC 654,362$11,772,0002.02%
DOHENY ASSET MANAGEMENT /CA 127,110$2,254,0001.79%
Granite Investment Partners, LLC 1,277,438$22,981,0001.49%
Amia Capital LLP 69,409$1,249,0001.11%
View complete list of HALOZYME THERAPEUTICS INC shareholders